“Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center”. Mediterranean Journal of Hematology and Infectious Diseases 18, no. 1 (April 30, 2026). Accessed June 30, 2026. https://www.mjhid.org/mjhid/article/view/6334.